Zobrazeno 61 - 70
of 80
pro vyhledávání: '"Peer Christiansen"'
Autor:
Jens Peter Garne, Peer Christiansen, Susanne Møller, Peter Vedsted, Ilse Vejborg, Niels Kroman, Holten Iw, Elsebeth Lynge
Publikováno v:
Christiansen, P, Vejborg, I, Kroman, N, Holten, I, Garne, J P, Vedsted, P, Møller, S & Lynge, E 2014, ' Comments to the paper : Influence of mammography screening on use of mastectomies in Denmark ', Acta Oncologica, vol. 54, no. 1, pp. 1-2 . https://doi.org/10.3109/0284186X.2014.920961
Christiansen, P, Vejborg, I, Kroman, N, Holten, I, Garne, J P, Vedsted, P, Møller, S & Lynge, E 2015, ' Comments to the paper : Influence of mammography screening on use of mastectomies in Denmark ', Acta Oncologica, vol. 54, no. 1, pp. 135-136 . https://doi.org/10.3109/0284186X.2014.920961
Christiansen, P, Vejborg, I, Kroman, N, Holten, I, Garne, J P, Vedsted, P, Møller, S & Lynge, E 2015, ' Comments to the paper : Influence of mammography screening on use of mastectomies in Denmark ', Acta Oncologica, vol. 54, no. 1, pp. 135-136 . https://doi.org/10.3109/0284186X.2014.920961
In the letter to the editor by Jorgensen et al. [1], the influence of mammography screening on mastectomy rates in Denmark is evaluated and discussed based on results from our recent published posi...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b3f12cd08e8fbeaa6e796087f15d89e
https://pure.au.dk/portal/da/publications/comments-to-the-paper(909e696c-e8fe-4d5d-85cd-7b1e07d89a0f).html
https://pure.au.dk/portal/da/publications/comments-to-the-paper(909e696c-e8fe-4d5d-85cd-7b1e07d89a0f).html
Autor:
Gitte Vrelits Sørensen, Peer Christiansen, Patricia A. Ganz, Lars Pedersen, Deirdre Cronin-Fenton, Henrik Toft Sørensen, Timothy L. Lash, Thomas P. Ahern, Steven W. Cole, Jens Peter Garne
Publikováno v:
Sørensen, G V, Ganz, P A, Cole, S W, Pedersen, L, Sørensen, H T, Cronin-Fenton, D, Garne, J P, Christiansen, P M, Lash, T & Ahern, T P 2013, ' Use of β-Blockers, Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Risk of Breast Cancer Recurrence : A Danish Nationwide Prospective Cohort Study ', Journal of Clinical Oncology . https://doi.org/10.1200/JCO.2012.43.9190
Sørensen, G V, Ganz, P A, Cole, S W, Pedersen, L A, Sørensen, H T, Cronin-Fenton, D, Garne, J P, Christiansen, P M, Lash, T & Ahern, T P 2013, ' Use of β-Blockers, Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Risk of Breast Cancer Recurrence : A Danish Nationwide Prospective Cohort Study ', Journal of Clinical Oncology, vol. 31, no. 18, pp. 2265-72 . https://doi.org/10.1200/JCO.2012.43.9190
Sørensen, G V, Ganz, P A, Cole, S W, Pedersen, L A, Sørensen, H T, Cronin-Fenton, D, Garne, J P, Christiansen, P M, Lash, T & Ahern, T P 2013, ' Use of β-Blockers, Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Risk of Breast Cancer Recurrence : A Danish Nationwide Prospective Cohort Study ', Journal of Clinical Oncology, vol. 31, no. 18, pp. 2265-72 . https://doi.org/10.1200/JCO.2012.43.9190
Purpose To estimate associations between use of β-blockers, angiotensin-converting enzyme (ACE) inhibitors, or angiotensin receptor blockers (ARBs) and breast cancer recurrence in a large Danish cohort. Patients and Methods We enrolled 18,733 women
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee2acce864f79e3295e918c002864c5a
https://pure.au.dk/portal/da/publications/use-of-blockers-angiotensinconverting-enzyme-inhibitors-angiotensin-ii-receptor-blockers-and-risk-of-breast-cancer-recurrence(0d006b08-814d-499c-8bcc-1c8bd055549d).html
https://pure.au.dk/portal/da/publications/use-of-blockers-angiotensinconverting-enzyme-inhibitors-angiotensin-ii-receptor-blockers-and-risk-of-breast-cancer-recurrence(0d006b08-814d-499c-8bcc-1c8bd055549d).html
Publikováno v:
Lyngholm, C D, Christiansen, P M, Damsgaard, T E & Overgaard, J 2013, ' Long-term follow-up of late morbidity, cosmetic outcome and body image after breast conserving therapy. A study from the Danish Breast Cancer Cooperative Group (DBCG) ', Acta Oncologica, vol. 52, no. 2, pp. 259-69 . https://doi.org/10.3109/0284186X.2012.744469
The Danish Breast Cancer Cooperative Group (DBCG) introduced BCT as a standard treatment in Denmark in 1990. The aim of this study was to investigate late morbidity, cosmetic outcome, and body image after BCT and to associate these outcome variables
Publikováno v:
Ugeskrift for laeger. 174(42)
Publikováno v:
Journal of Breast Cancer
Juhl, A A, Christiansen, P & Damsgaard, T E 2016, ' Persistent Pain after Breast Cancer Treatment : A Questionnaire-Based Study on the Prevalence, Associated Treatment Variables, and Pain Type ', Journal of Breast Cancer, vol. 19, no. 4, pp. 447-454 . https://doi.org/10.4048/jbc.2016.19.4.447
Juhl, A A, Christiansen, P & Damsgaard, T E 2016, ' Persistent Pain after Breast Cancer Treatment : A Questionnaire-Based Study on the Prevalence, Associated Treatment Variables, and Pain Type ', Journal of Breast Cancer, vol. 19, no. 4, pp. 447-454 . https://doi.org/10.4048/jbc.2016.19.4.447
PURPOSE: Persistent pain is a common side effect of breast cancer treatment. The present study aimed to assess the prevalence, associated treatment-related factors, and the type of pain (neuropathic or nociceptive) in patients who had undergone a uni
Autor:
Peer, Christiansen
Publikováno v:
Ugeskrift for laeger. 173(48)
Publikováno v:
Vestergaard, P, Fischer, L, Mele, M, Mosekilde, L & Christiansen, P 2011, ' Use of bisphosphonates and risk of breast cancer ', Calcified Tissue International, vol. 88, no. 4, pp. 255-62 . https://doi.org/10.1007/s00223-011-9463-7
A decreased risk of breast cancer has been reported among patients given bisphosphonates. The present aims were to study potential associations between different antiosteoporosis drugs, including bisphosphonates, and the risk of breast cancer before
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::304ccc4ce2d26fa1260870fd59238388
https://pure.au.dk/portal/da/publications/use-of-bisphosphonates-and-risk-of-breast-cancer(68122498-da7d-4afa-8132-00de60340b8f).html
https://pure.au.dk/portal/da/publications/use-of-bisphosphonates-and-risk-of-breast-cancer(68122498-da7d-4afa-8132-00de60340b8f).html
Autor:
Niels Kroman, Birgitte Bruun Rasmussen, Dorte B. Toftdahl, Marianne Ewertz, Susanne Møller, Henning T. Mouridsen, Peer Christiansen, Karsten Bjerre, Anne Vibeke Lænkholm, Maj-Britt Jensen, Birgitte Vrou Offersen, Bent Ejlertsen
Publikováno v:
Christiansen, P M, Bjerre, K D, Ejlertsen, B, Jensen, M-B, Rasmussen, B B, Lænkholm, A-V, Kroman, N, Ewertz, M, Offersen, B, Toftdahl, D B, Møller, S, Mouridsen, H T & Danish Breast Cancer Cooperative Group 2011, ' Mortality rates among early-stage hormone receptor-positive breast cancer patients: a population-based cohort study in Denmark ', National Cancer Institute. Journal
, vol. 103, no. 18, pp. 1363-72 . https://doi.org/10.1093/jnci/djr299
Christiansen, P, Bjerre, K, Ejlertsen, B L, Jensen, M-B, Rasmussen, B B, Lænkholm, A-V, Kroman, N T, Ewertz, M, Offersen, B V, Toftdahl, D B, Møller, S, Mouridsen, H T & Danish Breast Cancer Cooperative Group 2011, ' Mortality rates among early-stage hormone receptor-positive breast cancer patients: a population-based cohort study in Denmark ', Journal of the National Cancer Institute, vol. 103, no. 18, pp. 1363-72 . https://doi.org/10.1093/jnci/djr299
, vol. 103, no. 18, pp. 1363-72 . https://doi.org/10.1093/jnci/djr299
Christiansen, P, Bjerre, K, Ejlertsen, B L, Jensen, M-B, Rasmussen, B B, Lænkholm, A-V, Kroman, N T, Ewertz, M, Offersen, B V, Toftdahl, D B, Møller, S, Mouridsen, H T & Danish Breast Cancer Cooperative Group 2011, ' Mortality rates among early-stage hormone receptor-positive breast cancer patients: a population-based cohort study in Denmark ', Journal of the National Cancer Institute, vol. 103, no. 18, pp. 1363-72 . https://doi.org/10.1093/jnci/djr299
Indications for adjuvant endocrine treatment of breast cancer have gradually increased over the past several years. We aimed to define subgroups of patients who may or may not benefit from adjuvant endocrine therapy.A population-based cohort of syste
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2537dc3eab921e6f6c2dcbde516a5725
https://portal.findresearcher.sdu.dk/da/publications/cfe4de70-cc06-4a0a-8ea5-ca7bebea881f
https://portal.findresearcher.sdu.dk/da/publications/cfe4de70-cc06-4a0a-8ea5-ca7bebea881f
Publikováno v:
Ugeskrift for laeger. 172(41)
Surgical treatment for breast cancer is changing towards less extensive procedures and hence the need for hospitalisation is reduced. In order to investigate the organisation of such procedures, the choice of surgical procedures, length of hospitalis
Autor:
Vera, Peuckmann, Mogens, Grønvold, Ola, Ekholm, Niels Kristian, Rasmussen, Peer, Christiansen, Susanne, Møller, Per, Sjøgren
Publikováno v:
Ugeskrift for laeger. 172(8)
In this national survey, long-term breast cancer survivors (BCS) (n = 1,316) reported quality of life comparable to data from the general Danish female population, but a significantly higher prevalence of chronic pain (42% versus 32%). Paraesthesia,